Skip to main content
Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account?
Sign in